Pharming Group reports Q4 revenue of $106.5m, reaffirms 2026 guidance

Investing.com Gold reports: Pharming Group reports Q4 revenue of $106.5m, reaffirms 2026 guidance. This is a premium/paywalled source, so the brief is based on headline and available metadata only.